[Progress in diagnosis of and therapy for diabetic amyotrophy].
Kusaka
Hirofumi
H
D000449:Aldehyde Reductase / Q000037:antagonists & inhibitors; D000927:Anticonvulsants / Q000627:therapeutic use; D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use; D003929:Diabetic Neuropathies / Q000175:diagnosis* / Q000503:physiopathology / Q000628:therapy*; D003937:Diagnosis, Differential; D004568:Electrodiagnosis; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D007167:Immunotherapy; D018810:Magnetic Resonance Angiography; D009431:Neural Conduction; D010951:Plasma Exchange; D011241:Prednisone / Q000627:therapeutic use; D011379:Prognosis; D005719:gamma-Globulins / Q000008:administration & dosage
D000927:Anticonvulsants; D000929:Antidepressive Agents, Tricyclic; D004791:Enzyme Inhibitors; D007166:Immunosuppressive Agents; D005719:gamma-Globulins; D000449:Aldehyde Reductase; D011241:Prednisone